The inhibition of protein translation promotes tumor angiogenic switch

• Published in: Molecular biomedicine 2022-06, Vol.3 (1), p.18-18, Article 18
• Main Authors: Luo, Hui, Shen, Yuge, Liao, Weiting, Li, Qiqi, Wu, Ni, Zhong, Jian, Xiao, Chaoxin, Gan, Jia, Yang, Yun, Dong, E., Zhang, Guimin, Liu, Binrui, Yue, Xiaozhu, Xu, Lin, Liu, Yan, Zhao, Chengjian, Zhong, Qian, Yang, Hanshuo
• Format: Article
• Language: English
• Subjects: Angiogenic switch; Biomedical and Life Sciences; Biomedical Engineering/Biotechnology; Biomedicine; HIF; Microtumor; Molecular Medicine; Protein translation; Vegfa
• ISSN: 2662-8651; 2662-8651
• DOI: 10.1186/s43556-022-00081-4

The ‘angiogenic switch’ is critical for tumor progression. However, the pathological details and molecular mechanisms remain incompletely characterized. In this study, we established mammal xenografts in zebrafish to visually investigate the first vessel growth (angiogenic switch) in real-time, by inoculating tumor cells into the perivitelline space of live optically transparent Transgenic ( flk1:EGFP ) zebrafish larvae. Using this model, we found that hypoxia and hypoxia-inducible factor (HIF) signaling were unnecessary for the angiogenic switch, whereas vascular endothelial growth factor A gene ( Vegfa ) played a crucial role. Mechanistically, transcriptome analysis showed that the angiogenic switch was characterized by inhibition of translation, but not hypoxia. Phosphorylation of eukaryotic translation initiation factor 2 alpha (Eif2α) and the expression of Vegfa were increased in the angiogenic switch microtumors, and 3D tumor spheroids, and puromycin-treated tumor cells. Vegfa overexpression promoted early onset of the angiogenic switch, whereas Vegfa knockout prevented the first tumor vessel from sprouting. Pretreatment of tumor cells with puromycin promoted the angiogenic switch in vivo similarly to Vegfa overexpression, whereas Vegfa knockdown suppressed the increase . This study provides direc and dynamic in vivo evidences that inhibition of translation, but not hypoxia or HIF signaling promotes the angiogenic switch in tumor by increasing Vegfa transcription.